Cdc7-IN-8
Cdc7-IN-8 is a potent inhibitor of Cdc7. Cdc7 is a serine/threonine kinase which activates MCM promotion by phosphorylating the microchromosome maintenance protein (MCM protein), an important element of the DNA replication initiator. Cdc7-IN-8 has the potential for the research of cancer diseases (extracted from patent WO2021032170A1, compound 1-1/1-2) [1].
Product Specifications
CAS Number
2606780-38-3
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdc7-in-8.html
Solubility
10 mM in DMSO
Smiles
O=C1C2=C(C3=C(O2)C4=CNN=C4CCC3)N=C(N1)[C@@H]5CC6CCN5CC6
Molecular Formula
C19H21N5O2
Molecular Weight
351.40
References & Citations
[1]Lun Lu, et al. Tetracyclic compound used as cdc7 inhibitor. Patent WO2021032170A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Browse additional items from our catalog
Recombinant Streptococcus Pneumoniae rpsD Protein (aa 1-203) (strain P1031)
Hes5 Polyclonal Antibody, AbBy Fluor™ 488 Conjugated
Hes5 Polyclonal Antibody, AbBy Fluor™ 488 Conjugated
APP (Amyloid beta A4 Protein, ABPP, APPI, Alzheimer Disease Amyloid Protein, Cerebral Vascular Amyloid Peptide, CVAP, PreA4, Protease Nexin-II, PN-II, A4, AD1) (MaxLight 750) discontinued
NAP1 (5-azacytidine-Induced Protein 2, NF-kappa-B-activating Kinase-Associated Protein 1, Nak-Associated Protein 1, TILP, AZI2, NAP1, TBKBP2) (FITC)
